The Business Journals

FMC Corp. explores sale following $2.2B loss

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min A sale could add a new name to ...
Nieman Journalism Lab

Journalism coops seem utopian. What’s it like working in one?

Defector almost didn’t exist. When 19 former Deadspin staffers — who’d resigned in November 2019 after parent company G/O Media told them to “stick to sports” — decided to launch a new website, “we ...
IGN

Obsidian's The Outer Worlds 2 Underperformed, and There Won't Be a Third

Veteran role-playing game maker Obsidian Entertainment has no plans to continue The Outer Worlds with a third game, the studio has confirmed. On a more positive note, Grounded 2 — yet another 2025 ...
Us Weekly

What the ‘Landman’ Cast Has Said About Working With Creator Taylor Sheridan — Including How Often They Saw Him

Click to share on Facebook (Opens in new window) Facebook Click to share on X (Opens in new window) X “We knew we were making something really special. We thought people would like it. But the ...
Space.com

Rocket Lab launches its 1st mission of 2026, sending 2 satellites to orbit (video)

"The Cosmos Will See You Now" was Rocket Lab's 80th launch to date. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. Breaking space news, the ...
Seeking Alpha

GSK to buy RAPT Therapeutics in deal valued at $2.2B

GSK (GSK) has agreed to acquire RAPT Therapeutics (RAPT), a US-based biotech developing treatments for patients with inflammatory and immunologic diseases, in a deal valued at $2.2B. Under the terms ...
Gizmodo

‘Fallout’ Season 2’s Weekly Drops May Not Be Working

Reception to the new 'Fallout' season is good, but the audience just ain't there on a week-by-week basis. Reading time 1 minute The second season of Fallout came out in December, with a big switchup ...
FiercePharma

Acquisitive Sanofi keeps deals coming, laying out $2.2B for hepatitis vaccine maker Dynavax

Following a feud with activist investor Deep Track Capital in the first half of 2025, vaccine developer Dynavax Technologies has rounded out the year by agreeing to sell itself to France’s Sanofi. To ...
The Aviationist

Boeing Awarded $2 Billion Contract to Continue Work on B-52’s New Engines

The new contract covers the Post-Critical Design Review phase of the B-52 Commercial Engine Replacement Program, which will replace the TF33 engines with the new F130s. The U.S. Department of War ...
Nasdaq

Sanofi to Buy Dynavax for $2.2B to Boost Adult Vaccine Franchise

Sanofi SNY announced that it has entered into a definitive agreement to acquire Dynavax Technologies DVAX, a commercial-stage company, for $15.50 per share in cash, reflecting a total equity value of ...
Seeking Alpha

Strategy boosts cash reserve to ~$2.2B, pauses bitcoin purchases

Michael Saylor's Strategy (MSTR) increased the cash reserves it maintains to support the payment of dividends on its preferred stock and interest on its outstanding debt, and didn't acquire any ...